| HOME | HELP | FEEDBACK | TABLE OF CONTENTS | ARCHIVE | SUBSCRIPTIONS |
|
|
|
||||||
|
||||||||
Comparative Study |
Section of Haemato-Oncology, Institute of Cancer Research, London, UK.
BACKGROUND AND OBJECTIVES: The enzyme NAD(P)H:quinone oxidoreductase (NQO1) detoxifies chemicals with quinone rings including benzene metabolites and flavonoids. Previous studies in Caucasian populations have provided evidence that a loss of function allele at nt 609 (C609T, Pro187Ser) is associated with increased risk of infant acute lymphoblastic leukemia (ALL) with MLL-AF4 fusion genes. DESIGN AND METHODS: We genotyped 103 infants (<18 months) with ALL or acute myeloid leukemia (AML) in Japan and 185 controls for the frequency of allelic variation at nt 609 and 465 in NQO1 using standardized polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) methodology. RESULTS: The C609T polymorphism is very common in Japan but we found no link with altered risk for infant ALL. However, a variant of another allele at nt 465 (C465T, Arg139Trp), also associated with diminished enzyme activity, was strongly associated (OR 6.36; CI 1.84-21.90; p=0.002) with infant ALL, especially in t(4;11)(q21;q23), MLL-AF4. No association was found between this allele and risk of infant AML with MLL gene fusions or infant ALL without MLL gene fusions. The same C465T allele has been linked recently, in an Oriental population, to sensitivity to benzene hematotoxicity. INTERPRETATION AND CONCLUSIONS: These data endorse the notion that infant ALL with MLL fusion genes have a unique etiology possibly involving transplacental exposure to chemicals.
This article has been cited by other articles:
|
|
 |
|
  A. P. Chokkalingam and P. A. Buffler Genetic susceptibility to childhood leukaemia Radiat Prot Dosimetry, December 1, 2008; 132(2): 119 - 129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Guha, J. S. Chang, A. P. Chokkalingam, J. L. Wiemels, M. T. Smith, and P. A. Buffler NQO1 Polymorphisms and De Novo Childhood Leukemia: A HuGE Review and Meta-Analysis Am. J. Epidemiol., December 1, 2008; 168(11): 1221 - 1232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Stanulla, C. Dynybil, D. B. Bartels, M. Dordelmann, L. Loning, A. Claviez, and M. Schrappe The NQO1 C609T polymorphism is associated with risk of secondary malignant neoplasms after treatment for childhood acute lymphoblastic leukemia: a matched-pair analysis from the ALL-BFM study group Haematologica, November 1, 2007; 92(11): 1581 - 1582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Infante-Rivard, J. K. Vermunt, and C. R. Weinberg Excess Transmission of the NAD(P)H:Quinone Oxidoreductase 1 (NQO1) C609T Polymorphism in Families of Children with Acute Lymphoblastic Leukemia Am. J. Epidemiol., June 1, 2007; 165(11): 1248 - 1254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bolufer, M. Collado, E. Barragan, J. Cervera, M.-J. Calasanz, D. Colomer, J. Roman-Gomez, and M. A. Sanz The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia Haematologica, March 1, 2007; 92(3): 308 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Spector, S. M. Davies, L. L. Robison, J. M. Hilden, M. Roesler, and J. A. Ross Birth Characteristics, Maternal Reproductive History, and the Risk of Infant Leukemia: A Report from the Children's Oncology Group Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 128 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. G. Spector and J. A. Ross Infant Leukemia: Finding the Needle in the Haystack Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2331 - 2331. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | TABLE OF CONTENTS | ARCHIVE | SUBSCRIPTIONS |
